Vitamin D deficiency in younger
women is associated with increased risk of hypertension in mid-life
Vitamin D deficiency in premenopausal women may increase
the risk of developing systolic hypertension 15 years later, according to research
reported at the American Heart Association's 63rd High Blood Pressure Research
Conference.
Researchers examined women enrolled in the Michigan Bone
Health and Metabolism Study and analyzed data from 559 Caucasian women living
in Tecumseh, Mich. The ongoing study began in 1992 when the women were 24 to 44
years old with an average age of 38 years.
Researchers took blood pressure readings annually throughout
the study. They measured vitamin D blood levels once in 1993, and then compared
their systolic blood pressure measurements taken in 2007.
Premenopausal women who had vitamin D deficiency in 1993
had three times the risk of developing systolic hypertension 15 years later compared
to those who had normal levels of vitamin D, researchers said.
"This study differs from others because we are looking
over the course of 15 years, a longer follow-up than many studies," said Flojaune
C. Griffin, M.P.H., co-investigator of the study and a doctoral candidate in epidemiology
at the University of Michigan School of Public Health in Ann Arbor, Mich. "Our
results indicate that early vitamin D deficiency may increase the long-term risk
of high blood pressure in women at mid-life."
At the study onset, 2 percent of women had been diagnosed
or were being treated for hypertension and an additional 4 percent of the women
had undiagnosed systolic hypertension, defined as 140 millimeters of mercury (mm
Hg) or more. But 15 years later, 19 percent of the women had been diagnosed or
were being treated for hypertension and an additional 6 percent had undiagnosed
systolic hypertension, a significant difference.
Researchers controlled for age, fat mass, anti-hypertensive
medication use, and smoking.
Researchers determined vitamin D status by measuring
blood concentrations of 25-hydroxyvitamin D [25(OH)D] in 1993. 25(OH)D is a prehormone
in blood that is produced in the liver from the metabolism of vitamin D3 cholecalciferol.
Serum 25(OH)D is the primary form that is tested when examining vitamin D deficiency
because it represents vitamin D storage in the body. This assessment in the blood
reflects vitamin D obtained from ultraviolet B rays through sun exposure, vitamin
D from foods such as fatty fish or fortified milk products and dietary supplements.
The researchers did not examine the impact of these different sources of vitamin
D.
Vitamin D deficiency was defined as less than 80 nanomoles
per liter (nmol/L), while normal levels were considered more than 80 nmol/L. Experts
in the medical community generally agree that vitamin D deficiency among women
is widespread. Some researchers report many women don't get enough sunlight exposure
to help keep vitamin D levels near to normal, nor do they have diets or practice
supplementation that support normal levels of vitamin D, Griffin said.
However, Griffin said there's no general agreement about
the optimal intake of vitamin D. Some researchers said the current recommended
intake of 400 international units (IU) to 600 IU daily is inadequate and suggest
a much higher daily intake, from 1,000 IU to 5000 IU.
"Our study highlights the importance of vitamin D in
the risk of high blood pressure later in life, a major health problem in the United
States," Griffin said.
Co-authors are MaryFran R. Sowers, Ph.D., who directs
the Health Study, and Crystal A. Gadegbeku, M.D.
The National Institute of Arthritis and Musculoskeletal
and Skin Diseases funded the study.
|